The USDA is providing draft guidelines to allow for the preparation and electronic publishing of summaries for all efficacy and safety studies used to support vaccine licensing.

The AVMA commends the CVB for its progress on improving vaccine labels. The AVMA has repeatedly articulated the need for biologic labels to communicate an appropriate expectation of product performance to users of the products.